Familial adenomatous polyposis 3 is a rare inherited condition that causes many growths, called polyps, to form in the colon and rectum over time. Many people living with Familial adenomatous polyposis 3 are recognized in the teen years or early adulthood, and early symptoms of Familial adenomatous polyposis 3 may not appear until polyps become numerous or start to bleed. It may help to know that doctors have studied this condition for decades, and the main concern is a very high risk of colorectal cancer if it is not treated. Not everyone will have the same experience, but Familial adenomatous polyposis 3 is usually lifelong and care often includes regular colonoscopies, removal of polyps, and sometimes surgery to remove the colon. With close follow-up and timely treatment, many people with Familial adenomatous polyposis 3 can lower cancer risk and live much longer.
How many people live with Familial adenomatous polyposis 3?
Separate worldwide and U.S. counts for familial adenomatous polyposis 3 are not usually published on their own. For familial adenomatous polyposis as a whole, commonly cited estimates suggest roughly 0.8 to 1.6 million people worldwide (National Organization for Rare Disorders, 2023) and about 34,000 to 68,000 people in the United States (National Organization for Rare Disorders, 2023), but these are only rough estimates for the broader condition, not a direct count of type 3.
Overview
Familial adenomatous polyposis 3Symptoms
Familial adenomatous polyposis 3 often causes many colon polyps, sometimes starting in the teens. Early signs can include blood in the stool, belly pain, diarrhea, or anemia. Some people also develop growths in the stomach or small intestine.
Outlook and prognosis
With regular colon checks and timely treatment, many people with Familial adenomatous polyposis 3 can avoid bowel cancer or catch it early. Outlook also depends on growths outside the colon, so ongoing specialist follow-up matters.
Causes and risk factors
Familial adenomatous polyposis 3 is caused by a harmful change in the AXIN2 gene. It can be inherited from either parent, though some cases start new in the family. Lifestyle does not cause it, but smoking may raise bowel cancer risk.
Genetic influences
Genetics are central to Familial adenomatous polyposis 3, which is inherited and usually caused by a harmful change in a specific gene. Different genetic variations can affect when signs begin and how severe Familial adenomatous polyposis 3 may be.
Diagnosis
Familial adenomatous polyposis 3 is usually suspected from clinical features and a strong family history of many colon polyps, often at a young age. The genetic diagnosis of Familial adenomatous polyposis 3 is confirmed with genetic tests, sometimes along with colonoscopy findings.
Treatment and drugs
Familial adenomatous polyposis 3 is managed with colonoscopies and stomach or small-bowel checks to find and remove polyps early. If polyps become too numerous, preventive colon surgery may be advised. Ongoing genetic counseling and family screening help guide care.
Symptoms
Familial adenomatous polyposis 3 can affect day-to-day life quietly at first, because many people feel well until multiple polyps grow in the colon or rectum. These growths may cause bleeding, changes in bowel habits, belly discomfort, or low iron over time, but some are found only during screening. What once felt effortless can start to require more energy or focus when tiredness or frequent bathroom trips become part of the day.
Many people with familial adenomatous polyposis 3 have no obvious symptoms at first, even when polyps are already present. The early features of familial adenomatous polyposis 3 are often found during colonoscopy or because family history leads to testing.
The main feature is developing many polyps in the colon and rectum, sometimes starting at a young age. These growths usually cannot be felt directly, but they are the key sign doctors monitor because they can become cancerous.
Polyps can bleed, so you may notice bright red blood on toilet paper, in the bowl, or mixed with stool. Some bleeding is slow and hidden, so it may first show up as low iron on a blood test.
Some may find they have more diarrhea, constipation, urgency, or a feeling that the bowel did not empty fully. Day to day, it can feel like more planning around bathroom access or a routine that suddenly seems less predictable.
How people usually first notice Familial adenomatous polyposis 3?
How Familial adenomatous polyposis 3 is first noticed is often not through a dramatic symptom, but through a strong family history of colon polyps or colorectal cancer that prompts early screening. In many living with Familial adenomatous polyposis 3, the first signs are dozens to hundreds of colon polyps found on colonoscopy, sometimes along with rectal bleeding, changes in bowel habits, belly pain, or unexplained anemia from slow blood loss. Because these polyps usually begin forming in the teen years or early adulthood and may not cause symptoms right away, regular checkups and genetic testing can help families catch the condition early, before cancer develops.
Types of Familial adenomatous polyposis 3
No distinct types of Familial adenomatous polyposis 3 are widely recognized.
Can I slow down the onset of symptoms?
Probably not in a meaningful way: for familial adenomatous polyposis 3, the main driver is the inherited gene change itself, so healthy habits like exercise, not smoking, good sleep, and a balanced diet may support overall bowel and heart health but have not been shown to reliably delay when the condition starts, and they do not prevent it. Some medicines are being studied and may reduce or slow the growth of bowel polyps, which are small growths in the lining of the gut, but the best-proven medical approach is early regular bowel screening and, when needed, planned surgery to greatly lower cancer risk rather than stop the condition from appearing. Even though lifestyle changes cannot cancel out the genetic risk, staying engaged with specialist care can still make a real difference in catching problems early and protecting your health.
What genetics can tell you about symptoms
In familial adenomatous polyposis 3, the underlying genetic change can help explain why some people develop many colon and rectal polyps earlier in life, while others have fewer growths or develop problems later. Genetics may also influence how likely someone is to have related features outside the colon, but symptoms can still vary a lot, even among relatives with the same condition. In practice, genetic results can give clues about likely severity and timing, but they cannot predict exactly which symptoms someone will have or when they will start.
Causes and risk factors
The main cause of Familial adenomatous polyposis 3 is a harmful gene change that is usually inherited and can sometimes happen as a new mutation. A family history of Familial adenomatous polyposis 3 raises the chance that others in the family may carry the same change. Age and other gene changes in the body can influence how early polyps appear and how high the risk of bowel cancer becomes. On top of genetics, everyday habits also matter. Smoking, heavy alcohol use, extra body weight, low activity, and a diet high in red or processed meat may add to cancer risk, but they do not cause Familial adenomatous polyposis 3 by themselves.
What are the most common causes or risk factors?
Familial adenomatous polyposis 3 is mainly caused by an inherited gene change that makes many polyps, or small growths, form in the colon and rectum, so the biggest risk factor is having a parent or close family member with this condition, lots of bowel polyps, or colorectal cancer at a young age. In some people, the gene change starts for the first time in them even without a family history, and there are no well-proven lifestyle or environmental factors known to cause the condition itself, although getting older raises the chance that the polyps will grow and turn into cancer over time.
Environmental and biological risk factors
Familial adenomatous polyposis 3 is usually present from the very start of life, so the main risk factors for familial adenomatous polyposis 3 are internal rather than environmental. In practical terms, risk is linked much more to what was passed on before birth than to something encountered later. Unlike many common conditions, no everyday environmental trigger has been clearly shown to cause familial adenomatous polyposis 3.
The strongest risk factor is a family pattern of familial adenomatous polyposis 3 or a closely related polyposis condition. If a parent or several close relatives are affected, the chance is higher that the same condition-related change is present in the family.
If one parent carries the condition-related change, a child can inherit it at conception. This is why family history on either side of the family matters when doctors assess risk.
Sometimes familial adenomatous polyposis 3 appears for the first time in a family because a new change happens in the egg, sperm, or very early embryo. When this happens, there may be no earlier family history.
Rarely, a parent may carry the condition-related change in only some egg or sperm cells and have no obvious signs themselves. This can lead to an affected child even when the family history seems negative.
Genetic risk factors
Most cases of Familial adenomatous polyposis 3 are linked to inherited changes in AXIN2, a gene involved in controlling cell growth in the bowel. The main genetic risk is having one altered copy of this gene, often passed down from a parent, although some people are the first in their family to carry it. Risk is not destiny—it varies widely between individuals. Missing several permanent teeth can be an early clue in some families.
AXIN2 changes: Familial adenomatous polyposis 3 is most often caused by a harmful change in the AXIN2 gene. This gene helps control cell growth in the bowel, so a change can raise the chance of many precancerous polyps and colorectal cancer.
Dominant inheritance: The condition usually follows an autosomal dominant pattern, meaning one altered copy of AXIN2 can increase risk. If a parent carries the change, each child has a 1 in 2, or 50%, chance of inheriting it.
New gene change: Sometimes the AXIN2 change starts for the first time in one family member instead of being inherited. This means Familial adenomatous polyposis 3 can appear even when no relative is known to have polyps or colorectal cancer.
Family history: A family pattern of many colon polyps, early colorectal cancer, or both makes an inherited cause more likely. When people ask about the genetic risk factors for Familial adenomatous polyposis 3, this kind of family history is one of the biggest clues.
Missing teeth: Some people with AXIN2-related Familial adenomatous polyposis 3 are born without several permanent teeth, which is called oligodontia. When missing teeth and polyps or colorectal cancer occur in the same family, it can point strongly to this inherited syndrome.
Lifestyle risk factors
Familial adenomatous polyposis 3 is inherited, so lifestyle habits do not cause it. Still, how lifestyle affects Familial adenomatous polyposis 3 can matter because everyday habits may influence inflammation, bowel symptoms, recovery after treatment, and the risk of complications such as colorectal or upper gastrointestinal cancer. The most useful lifestyle risk factors for Familial adenomatous polyposis 3 are the ones that can worsen polyp-related disease or make long-term management harder.
Smoking does not cause Familial adenomatous polyposis 3, but it may add to the risk of colorectal and other digestive tract cancers in someone who is already genetically predisposed. It can also impair healing after endoscopic procedures or surgery and may worsen overall long-term outcomes.
Heavy alcohol intake may increase irritation and inflammation in the digestive tract, which is unhelpful in a condition marked by ongoing polyp formation. It can also raise the risk of some gastrointestinal cancers and interfere with nutrition or recovery after treatment.
A diet high in processed meats, red meat, and highly processed foods may contribute to a bowel environment linked with greater cancer risk. In contrast, balanced eating with adequate fiber when tolerated, fruits, vegetables, and healthy fats may support bowel health, although it does not remove the inherited risk.
Physical inactivity can promote weight gain, insulin resistance, and chronic low-grade inflammation, all of which may unfavorably affect cancer risk over time. Regular physical activity may support bowel function, metabolic health, and recovery during long-term surveillance or after surgery.
Risk prevention
Familial adenomatous polyposis 3 is an inherited condition, so there is no proven way to prevent the condition itself from being passed down or from starting. Prevention is mainly about lowering the risk of colorectal cancer and other related cancers by finding growths early and treating them before they turn dangerous. Some prevention is universal, others are tailored to people with specific risks. For many living with familial adenomatous polyposis 3, this often means a long-term plan that starts before any symptoms appear.
If familial adenomatous polyposis 3 runs in your family, genetic counseling and testing can show who has a higher cancer risk and who does not. This helps people start the right screening at the right age and can guide family planning decisions.
Regular colonoscopy or sigmoidoscopy is one of the main ways to prevent cancer in familial adenomatous polyposis 3. These tests can find and remove polyps early, often before early symptoms of familial adenomatous polyposis 3 cause problems.
When polyps become too numerous or high risk, surgery to remove the colon may be the safest way to prevent colorectal cancer. Doctors tailor the timing to the polyp burden, age, symptoms, and overall health.
Familial adenomatous polyposis 3 can also raise the risk of polyps in the stomach and first part of the small intestine. Regular upper endoscopy can help catch these changes early so they can be watched or treated.
Can you prevent Familial adenomatous polyposis 3?
No, you cannot prevent familial adenomatous polyposis 3 itself, because it is an inherited condition that people are born with. If it runs in your family, genetic counseling and testing may help find it early. While this cannot stop the condition from happening, regular checks of the colon and prompt treatment can help prevent some of its most serious problems, especially colon cancer.
Transmission
Familial adenomatous polyposis 3 is not contagious, so it cannot be spread by touch, kissing, sex, blood, food, or the air. Instead, it is a genetic condition that runs in families.
In most families, how Familial adenomatous polyposis 3 is inherited follows an autosomal recessive pattern, which means a child usually needs to receive one altered copy of the gene from each parent to develop the condition. If both parents are carriers, each pregnancy has a 25% chance of the child having Familial adenomatous polyposis 3, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy.
When to test your genes
Consider genetic testing if you or close relatives have dozens of colon polyps, colorectal cancer at a young age, or a known familial adenomatous polyposis gene change. If FAP is confirmed, the result helps tailor colonoscopy timing, surgery decisions, and testing for relatives who may also be at risk.
Diagnosis
Familial adenomatous polyposis 3 is usually suspected when many colon polyps appear at a young age or when there is a strong family history of colorectal cancer or polyps. In this condition, diagnosis often starts with patterns doctors can see in the colon and is then confirmed with specific genetic tests. Early and accurate diagnosis can help you plan ahead with confidence.
A detailed family and health history can help doctors spot an inherited pattern of colon polyps, colorectal cancer, or related tumors. This is often an important first clue in the diagnosis of familial adenomatous polyposis 3.
Doctors usually look inside the colon and rectum with a camera test to check for large numbers of adenomatous polyps. Finding many polyps, especially at a younger age, strongly raises concern for familial adenomatous polyposis 3.
Because this condition can also affect the stomach and first part of the small intestine, doctors may examine these areas with a thin flexible camera. This helps show how widespread the condition is and can guide follow-up care.
Blood or saliva testing can look for the inherited gene change linked to familial adenomatous polyposis 3. The genetic diagnosis of familial adenomatous polyposis 3 can confirm the cause and help identify relatives who may also need testing.
How is Familial adenomatous polyposis 3 diagnosed?
Familial adenomatous polyposis 3 is usually diagnosed when a doctor finds many polyps, which are small growths, in the colon and rectum during a colonoscopy, a camera test that looks inside the bowel, and also reviews your personal and family history. Small samples of these growths may be checked under a microscope to confirm the type of polyp. Genetic testing on a blood or saliva sample can help confirm the inherited cause and identify other family members who may also need screening.
Stages of Familial adenomatous polyposis 3
Familial adenomatous polyposis 3 does not have defined progression stages. That is because it is an inherited cancer-risk condition identified by the tendency to develop many colon polyps over time, rather than a disease that moves through clear step-by-step phases. Often the process begins when you notice changes in daily life, but many people with familial adenomatous polyposis 3 have no early symptoms and learn about it after a family history review, a colonoscopy, or genetic testing. Doctors usually monitor it with regular colon checks and, when needed, upper digestive tract exams, because early symptoms of familial adenomatous polyposis 3 can be absent even when polyps are already present.
Outlook and prognosis
The outlook for familial adenomatous polyposis 3 depends largely on how early it is recognized and how consistently colonoscopic surveillance, preventive surgery, and screening for upper gastrointestinal and other associated tumors are carried out. Without treatment, the lifetime risk of colorectal cancer is extremely high, and cancer has historically been the main cause of premature death. With timely colectomy when needed and regular lifelong follow-up, many affected people can avoid colorectal cancer and have a markedly improved, sometimes near-normal, life expectancy. Prognosis is also influenced by the severity of the polyp burden and whether desmoid tumors, duodenal cancer, thyroid cancer, or other extracolonic complications develop. Because this is a lifelong cancer-predisposition syndrome, ongoing specialist care remains essential even after colon surgery.
Long-term effects
For many living with familial adenomatous polyposis 3, the biggest long-term concern is the tendency to develop many growths in the colon and rectum over time, which can raise cancer risk if they are not found and treated. Long-term effects vary widely, and some people mainly deal with bowel-related problems while others also develop changes in the stomach, small intestine, or other tissues. The long-term effects of familial adenomatous polyposis 3 can also differ by age, with some features showing up in the teen years and others becoming more important in adulthood. Even within the same family, the outlook can be quite different from one person to another.
The most important long-term effect is a very high lifetime risk of colorectal cancer because new polyps can keep forming in the colon and rectum. This risk usually rises with age and may become serious in early adulthood if the condition is not closely monitored.
Many people with familial adenomatous polyposis 3 have repeated colon and rectal polyps over years, and these can cause bleeding, anemia, diarrhea, mucus, or changes in bowel habits. In some, the rectum or bowel can remain an area of concern even after earlier treatment.
Polyps can also develop in the stomach and especially the first part of the small intestine, called the duodenum. Over time, some of these growths can become precancerous or cancerous, so the upper digestive tract may remain part of the long-term picture.
Some people with familial adenomatous polyposis 3 develop desmoid tumors, which are growths in connective tissue rather than typical bowel polyps. These do not usually spread to distant organs, but they can press on nearby structures and sometimes cause long-term pain, blockage, or other complications.
How is it to live with Familial adenomatous polyposis 3?
Living with familial adenomatous polyposis 3 often means weaving medical care into ordinary life, because many living with this condition need regular colonoscopies, monitoring for polyps in other parts of the digestive tract, and sometimes preventive surgery to lower the very high risk of colorectal cancer. Day to day, that can bring stress, planning around appointments and recovery, and the emotional weight of knowing this is an inherited condition, but many people are able to work, study, raise families, and keep a full routine with the right follow-up care. It can affect loved ones too, since relatives may need genetic counseling and testing, and families often have to navigate worry, practical support, and long-term health decisions together.
Treatment and drugs
Familial adenomatous polyposis 3 is treated by closely watching for new growths in the digestive tract and lowering the very high risk of colorectal cancer, often with a mix of regular screening, procedures to remove polyps, and surgery when needed. Because polyps can keep coming back, many people with familial adenomatous polyposis 3 are advised to have part or all of the colon removed at some point, and some also need monitoring or treatment for growths in the stomach or small intestine. Treatment plans often combine several approaches. Medicines do not replace surgery, but some drugs may be used in selected cases to help reduce the number or size of polyps, and care usually includes lifelong follow-up with a gastroenterologist, surgeon, and genetics team.
Can you cure Familial adenomatous polyposis 3?
No, there is currently no cure for familial adenomatous polyposis 3, because it is an inherited condition that makes the body prone to growing many polyps, or small growths, in the bowel. Treatment cannot remove the underlying genetic cause, but regular checkups, removing polyps, and sometimes surgery to remove part or all of the large intestine can greatly lower the risk of bowel cancer and help manage problems. Doctors may also keep an eye on other parts of the body and treat symptoms if they appear.
Non-drug treatment
Living with Familial adenomatous polyposis 3 often means planning ahead, because cancer prevention usually depends more on close monitoring and procedures than on daily medicine. For many, treatment begins not at the pharmacy, but with regular scopes, surgery when needed, and follow-up care tailored to the parts of the body most at risk. The main goals of non-drug treatment for Familial adenomatous polyposis 3 are to find growths early, remove them when possible, and lower the chance of colorectal and other related cancers. Care is often coordinated by a gastroenterologist, surgeon, genetic specialist, and other doctors depending on your needs.
Regular colonoscopy is a core part of care because many people with Familial adenomatous polyposis 3 develop large numbers of colon polyps over time. These exams help doctors find and remove concerning growths before they turn into cancer. The schedule is individualized, but screening often starts earlier than it does for the general public.
Polyps can also form in the stomach and the first part of the small intestine, so upper endoscopy is often used alongside colon checks. This can matter even when day-to-day symptoms are mild or absent. Alongside medicines, non-drug therapies include repeated surveillance to catch changes early.
During endoscopy, doctors can often remove larger or more suspicious polyps without making an incision. This may lower cancer risk and can delay bigger procedures in some people. Not every approach works the same way, so repeated treatment may still be needed as new polyps appear.
If the colon has too many polyps to manage safely, surgery to remove part or all of the colon may be recommended. This is often the most effective way to reduce colorectal cancer risk in Familial adenomatous polyposis 3. The exact operation depends on polyp burden, age, rectal involvement, and personal goals.
Your genes may have an impact on how drugs work for you
For people with familial adenomatous polyposis 3, medicines are sometimes used to help slow the growth of colon polyps, but they do not replace close screening or surgery when needed. Inherited differences in how the body handles medicine can affect how well these treatments work and how likely side effects are, so one person may have a good response while another may get less benefit or more stomach, kidney, or heart-related problems. Even so, for this condition, treatment choices are still based mostly on how many polyps are present, where they are, and a person’s overall health, rather than on special drug-response gene testing.
Pharmacological treatments
For many living with familial adenomatous polyposis 3, medicines may help lower the number or size of some polyps, but they do not replace regular scopes or surgery when needed. The drugs used most often are celecoxib and sulindac, both anti-inflammatory medicines that can reduce polyp burden in some people. In selected cases, doctors may also consider erlotinib, usually together with sulindac, especially when trying to slow upper digestive tract polyps. Not everyone responds to the same medication in the same way.
Celecoxib is a prescription anti-inflammatory drug that can reduce the number and size of colorectal polyps in some people with familial adenomatous polyposis 3. It is usually used as an add-on to close monitoring, not as a substitute for colectomy or regular colonoscopy.
Sulindac is another anti-inflammatory medicine that has been used to shrink or slow the return of polyps, especially in the colon or rectum after surgery. Its effect can vary, so doctors usually follow people closely for early symptoms of familial adenomatous polyposis 3 complications and for ongoing polyp growth.
Erlotinib is a targeted cancer drug that has shown benefit in some studies when combined with sulindac, particularly for duodenal polyps in familial adenomatous polyposis 3. Because side effects can be limiting, it is generally reserved for carefully selected situations.
Medicines such as acetaminophen or other pain relievers may be used if treatment, procedures, or related problems cause discomfort. These drugs do not treat the polyps themselves, but they can help with day-to-day symptoms while the main treatment plan continues.
Genetic influences
When colon polyps, colorectal cancer, or several missing adult teeth show up in more than one generation, it can be a clue to Familial adenomatous polyposis 3. This named subtype has a confirmed genetic cause: a harmful change in the AXIN2 gene. It is usually inherited in an autosomal dominant pattern, meaning one changed copy of the gene is enough to raise risk and each child of an affected parent has a 50% chance of inheriting it. The way Familial adenomatous polyposis 3 shows up can still vary, so one relative may develop many polyps while another is first noticed because of dental findings or fewer early symptoms of Familial adenomatous polyposis 3. To put these pieces together, doctors may suggest genetic counseling.
Is Familial adenomatous polyposis 3 genetic?
Genetics are central to Familial adenomatous polyposis 3, which is inherited and usually caused by a harmful change in a specific gene. Different genetic variations can affect when signs begin and how severe Familial adenomatous polyposis 3 may be.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of being human and are widely found in the general population. Most do not directly affect health and simply reflect natural differences among people. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Familial adenomatous polyposis 3, the inherited gene change is one of the main reasons doctors plan very close screening and sometimes preventive surgery, because this condition can lead to repeated growth of colon polyps and raise cancer risk over time. The genetic result can help guide how early screening starts, how often the colon and upper digestive tract are checked, and which close relatives should be offered testing. Genetics is only one factor, but for many living with Familial adenomatous polyposis 3, medicines are usually an add-on rather than a cure: some anti-inflammatory drugs may lower the number or size of polyps in certain people, yet they do not replace regular exams or surgery when risk is high.
Right now, there is no routine pharmacogenetic test that clearly shows which polyp-reducing drug will work best for Familial adenomatous polyposis 3, so treatment is still based mostly on the gene finding, the number and behavior of polyps, age, symptoms, and personal cancer history. Genetic testing for Familial adenomatous polyposis 3 can also help tailor care for family members before problems begin.
Interactions with other conditions
For many living with Familial adenomatous polyposis 3, the biggest concern is not just the colon polyps themselves, but how they can lead to other serious conditions over time, especially colorectal cancer. This condition can also overlap with other problems in the digestive tract, so stomach or bowel symptoms should not automatically be blamed on common issues like hemorrhoids, irritable bowel syndrome, or simple indigestion. Doctors call it a “comorbidity” when two conditions occur together, and that matters here because another bowel problem can sometimes mask warning signs such as bleeding, anemia, or changes in bowel habits. In some families, Familial adenomatous polyposis 3 is also linked with missing adult teeth, and that dental finding can be an important clue that helps connect mouth changes with a higher risk of colon disease. Because the exact pattern can vary from one family to another, people with Familial adenomatous polyposis 3 often benefit from coordinated care that includes both cancer screening and attention to any other digestive or dental conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Familial adenomatous polyposis 3?
Other inherited bowel conditions can look similar, especially MUTYH-associated polyposis, Lynch syndrome, juvenile polyposis syndrome, Peutz-Jeghers syndrome, and serrated polyposis syndrome, because they can also cause multiple polyps, bleeding, and a higher risk of bowel cancer. If someone has bleeding from the rectum, belly pain, or changes in bowel habits, doctors may also consider more common problems such as hemorrhoids, inflammatory bowel disease, or polyps that are not inherited.
History
Long before there were genetic tests, some families noticed a striking pattern: relative after relative developed large numbers of growths in the bowel, sometimes followed by bowel cancer at a young age. For many, this history was not just a medical detail. It shaped when people sought care, how often they needed checkups, and why several generations might talk about stomach or bowel trouble in the same family.
By the late 1800s and early 1900s, doctors had begun publishing reports of these family patterns and the many polyps seen in the colon and rectum. Medical classifications changed as researchers learned that what first seemed like one broad condition actually included more than one form of inherited polyposis. Over time, advances in endoscopy, pathology, and later genetic research made it easier to separate similar disorders from each other, including forms now grouped under names such as familial adenomatous polyposis 3.
That shift mattered in everyday care. Once doctors could recognize these syndromes earlier, people with familial adenomatous polyposis 3 were more likely to be offered regular bowel screening before cancer developed, rather than only being diagnosed after symptoms appeared. In more recent years, awareness has also improved among families with a strong history of colon polyps or early bowel cancer, which can help explain why the early symptoms of familial adenomatous polyposis 3 are often looked for more carefully today. Even so, because these conditions can overlap, the history of familial adenomatous polyposis 3 is still closely tied to the broader story of how medicine learned to identify inherited bowel polyposis more accurately.